Blockade of the ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22α-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 683-691

  Dong, Li Hua ^a   Wen, Jin Kun ^a   Liu, George ^c   McNutt, Michael A ^d   Miao, Sui Bing ^a   Gao, Rui ^a   Zheng, Bin ^a   Zhang, Hailin ^a,b   Han, Mei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c Education Commission of China   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Neointimal hyperplasia; Proliferation; Smooth muscle 22 Ras; Vascular smooth muscle cells

Indexed keywords

GLUTATHIONE TRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BB; RAF PROTEIN; RAS PROTEIN; TRANSGELIN; ACTIN BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MUSCLE PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; RAF 1 PROTEIN, RAT; RAF-1 PROTEIN, RAT;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; BALLOON DILATATION; CAROTID ARTERY INJURY; CELL CULTURE; CELL CYCLE; CELL DEDIFFERENTIATION; DISEASE MODEL; DOWN REGULATION; ENZYMOLOGY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; HYPERPLASIA; INJURY; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; TIME; VASOCONSTRICTION;

ADENOVIRIDAE; ANIMALS; BALLOON DILATATION; CAROTID ARTERY INJURIES; CELL CYCLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENETIC VECTORS; HUMANS; HYPERPLASIA; IMMUNOPRECIPITATION; MALE; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE KINASE KINASES; MICROFILAMENT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VASOCONSTRICTION;

EID: 77950869752     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.200501     Document Type: Article

References (32)

1. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256.
2. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37-40.
3. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 2004;6:872-883.
4. Morgan DO. Principles of CDK regulation. Nature. 1995;374:131-134.
5. Zheng B, Han M, Bernier M, Zhang XH, Meng F, Miao SB, He M, Zhao XM, Wen JK. Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor/3-mediated, not by retinoic acid receptor a-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J Biol Chem. 2009;284:22773-22785.
6. Marra DE, Simoncini T, Liao JK. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Circulation. 2000;102:2124-2130.
7. Hu Y, Cheng L, Hochleitner BW, Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17: 2808-2816.
8. Yokouchi K, Numaguchi Y, Kubota R, Ishii M, Imai H, Murakami R, Ogawa Y, Kondo T, Okumura K, Ingber DE, Murohara T. L-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler Thromb Vasc Biol. 2006;26:2231-2237.
9. Fu Y, Liu HW, Forsythe SM, Kogut P, McConville JF, Halayko AJ, Camoretti-Mercado B, Solway J. Mutagenesis analysis of human SM22: characterization of actin binding. J Appl Physiol. 2000;89:1985-1990.
10. Winder SJ, Jess T, Ayscough KR. SCP1 encodes an actin-bundling protein in yeast. Biochem J. 2003;375:287-295.
11. Han M, Wen JK, Zheng B, Cheng Y, Zhang C. Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol Cell Physiol. 2006;291:C50-C58.
12. Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res. 2008;102:1548-1557.
13. Han M, Dong LH, Zheng B, Shi JH, Wen JK, Cheng Y. Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundling. Life Sci. 2009;84: 394-401.
14. Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, Strobeck M, Yu Q, Parmacek MS. Analysis of SM22a-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol. 2001;21:1336-1344.
15. Feil S, Hofmann F, Feil R. SM22a modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res. 2004;94:863-865.
16. Nair RR, Solway J, Boyd DD. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem. 2006;281:26424-26436.
17. Zheng B, Wen JK, Han M. hhLIM is a novel F-actin binding protein involved in actin cytoskeleton remodeling. FEBS J. 2008;275: 1568-1578.
18. Wakino S, Kintscher U, Kim S, Jackson S, Yin F, Nagpal S, Chandraratna RA, Hsueh WA, Law RE. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol. 2001;21:746-751.
19. Goumans MJ, Liu Z, ten Dijke P. TGF-/3 signaling in vascular biology and dysfunction. Cell Res. 2009;19:116-127.
20. Wang C, Han M, Zhao XM, Wen JK. Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem. 2008;144:313-321.
21. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998;98: 82-89.
22. Zeidan A, Nordstrom I, Albinsson S, Malmqvist U, Sward K, Hellstrand P. Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors. Am J Physiol Cell Physiol. 2003;284:C1387-C1396.
23. Hunter T. Braking the cycle. Cell. 1993;75:839-841.
24. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol. 1994;14:1669-1679.
25. Delmas C, Manenti S, Boudjelal A, Peyssonnaux C, Eychene A, Darbon JM. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells. J Biol Chem. 2001;276:34958-34965.
26. Lai K, Wang H, Lee WS, Jain MK, Lee ME, Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest. 1996;98:1560-1567.
27. Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res. 1997;81:904-910.
28. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, Kaneda Y, Morishita R, Zhan Y, Iwao H. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res. 2001;88:1120-1126.
29. Leinweber BD, Leavis PC, Grabarek Z, Wang CL, Morgan KG. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J. 1999; 344(pt 1):117-123.
30. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96:2260-2268.
31. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001;104: 2710-2715.
32. Maillard L, Van Belle E, Tio FO, Rivard A, Kearney M, Branellec D, Steg PG, Isner JM, Walsh K. Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries. Gene Ther. 2000;7:1353-1361.